RIVFLOZA
NDC 0169-5308, nedosiran, injection, solution, from Novo Nordisk.
- Product NDC
- 0169-5308
- Status
- Listed
- Labeler
- Novo Nordisk
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215842
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0169-5308 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEDOSIRAN SODIUM80 mg/.5mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0169-5308-01 | 00169530801 | 1 VIAL in 1 CARTON (0169-5308-01) / .5 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ace9d4bc-4d20-4beb-9e9d-888690424833
Use it
Look up 0169-5308 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0169-5308 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0169-5308. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.